Effects of Adrenergic .ALPHA.2-Receptor Agonists on Urinary Bladder Contraction in Conscious Rats.

DOI Web Site Web Site Web Site Web Site View 1 Remaining Hide 34 References
  • Kontani Hitoshi
    Department of Pharmacology, Faculty of Pharmaceutical Science, Hokuriku University, Kanagawa-machi, Kanazawa 920-1181, Japan
  • Tsuji Toshitsugu
    Department of Pharmacology, Faculty of Pharmaceutical Science, Hokuriku University, Kanagawa-machi, Kanazawa 920-1181, Japan
  • Kimura Satoko
    Department of Pharmacology, Faculty of Pharmaceutical Science, Hokuriku University, Kanagawa-machi, Kanazawa 920-1181, Japan

Bibliographic Information

Other Title
  • Effects of Adrenergic α2-Receptor Agonists on Urinary Bladder Contraction in Conscious Rats
  • Effects of Adrenergic アルファ 2 Receptor Agonists on Urinary Bladder Contraction in Conscious Rats

Search this article

Abstract

We investigated the effects of the adrenergic α2-receptor agonists clonidine, oxymetazoline and tizanidine on bladder contractions induced by infusing fluid into the bladders of conscious male rats. I.v. clonidine and oxymetazoline (both 0.01 to 0.1 mg/kg) caused bladder hyperactivity, expressed by shortening of the intercontraction interval. Tizanidine (0.1 mg/kg, i.v.) caused slight shortening of the intercontraction interval. The rank order of potency was clonidine=oxymetazoline >> tizanidine. Intrathecal (i.t.) injection of 10 μg clonidine and oxymetazoline, and intracerebroventricular (i.c.v) injection at 15 μg, produced almost the same pattern of bladder hyperactivity as that observed after i.v. injection of these drugs (0.03 mg/kg, i.v.). For all three administration routes of clonidine and oxymetazoline, i.v. idazoxan (0.3 mg/kg) exerted an inhibitory effect on the bladder hyperactivity induced by these drugs, except i.c.v injection of oxymetazoline. I.t. phenylephrine (30 μg) did not change the intercontraction interval. Although i.c.v. phenylephrine (15 μg) shortened the intercontraction interval, the potency was weaker than those of i.c.v. clonidine and oxymetazoline (15 μg). These results suggest that clonidine and oxymetazoline cause bladder hyperactivity by acting at adrenergic α2 receptors in the micturition centers of the lumbosacral and supraspinal regions.

Journal

References(34)*help

See more

Details 詳細情報について

Report a problem

Back to top